Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04995848
Other study ID # N-20200094
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 26, 2021
Est. completion date August 1, 2024

Study information

Verified date July 2023
Source Aalborg University
Contact Birthe Dinesen, MSc, PhD
Phone +4520515944
Email bid@hst.aau.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project has focus on patients in palliation testing a digital platform TelePal.dk.


Description:

The aim of the RCT study is to: • Test, implement, and evaluate a telepalliation program for patients receiving palliative care (cancer, heart failure (HF), COPD, and motor neuron disease) from a clinical, psychosocial, inter-organizational, and health economic perspective.


Recruitment information / eligibility

Status Recruiting
Enrollment 182
Est. completion date August 1, 2024
Est. primary completion date August 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Over 18 years - Live in Esbjerg, Varde, Billund, Fanø or Vejen Municipality - Cancer, heart failure, chronic obstructive pulmonary disease (COPD), and motor neuron disease (neurological diseases) referred to the Palliation Team at Southwest Jutland Hospital - Basic computer skills or a relative who has basic computer skills Exclusion Criteria: - Delirium at enrolment based on CAM score - Active psychiatric history (as noted in the medical record) other than depression or anxiety related to the main diagnosis referred to palliative care - Lack of ability to cooperate

Study Design


Intervention

Other:
Telepalliation
Telepalliation platform Telepal.dk

Locations

Country Name City State
Denmark Palliative Team, South West Jutland Hospital ESbjerg

Sponsors (5)

Lead Sponsor Collaborator
Aalborg University Center for Innovative Medical Technologies (CIMT), Odense University Hospital, Danish Cancer Society, Laboratory of Welfare Technology, Department of Health Science and Technology, Aalborg University, Palliative Team,Hospital of South West Jutland

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Quality of life Measured by the European Organization for Research and Treatment of Cancer, questionnaire regarding quality of life in palliative cancer care patients (EORTC QLQ-C15-PAL). At baseline, week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26
Secondary Changes in medicine Information on medicine for both groups will be collected at enrolment and every week from the electronic patient record (EPR). Changes in medicine over time will be analyzed. At enrolment and week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26
Secondary Changes in feeling of security Measured on a likert scale At baseline, twice every week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26
Secondary Experiences of pain Numerical Rating Scale (NRS) At baseline, week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26
Secondary Experience of pain (brief) Brief Pain Inventory, short form (BPI-sf) At baseline, week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26
Secondary Experiences of patients on the actual use of the TelePal.dk platform and their experiences of being a part of a telepalliation program Qualitative interviews Week 4
Secondary Experiences of relatives on the actual use of the TelePal.dk platform and their experiences of being a part of a telepalliation program Qualitative interviews Week 4 and 3 months
Secondary Experiences of health care professionals on the actual use of the TelePal.dk platform and their experiences of being a part of a telepalliation program Qualitative interviews 6 months and 12 months
Secondary Perceptions on usability of a cross-sector communication platform and telerehabilitation program by patients, relatives and health care professionals Qualitative interviews 12 months
Secondary Observations on usability of a cross-sector communication platform and telerehabilitation program by patients, relatives and health care professionals Observations 12 months
Secondary Health related quality of life Measured by EQ-5D Health Questionnaire week 1 and week 4
Secondary Cost of healthcare services Cost-effectiveness analysis ((number of phone/video calls, equipment, driving, personal use in palliative care (video and home visits), visits to general practitioner and outpatient clinic, hospitalizations, readmissions and length of stay, visits from palliative team)) 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients